Related references
Note: Only part of the references are listed.Genome-Scale Screening of Drug-Target Associations Relevant to Ki Using a Chemogenomics Approach
Dong-Sheng Cao et al.
PLOS ONE (2013)
Large-scale prediction of drug-target interactions using protein sequences and drug topological structures
Dong-Sheng Cao et al.
ANALYTICA CHIMICA ACTA (2012)
Relating drug-protein interaction network with drug side effects
Sayaka Mizutani et al.
BIOINFORMATICS (2012)
Target-drug interactions: first principles and their application to drug discovery
Sara Nunez et al.
DRUG DISCOVERY TODAY (2012)
Computer-aided prediction of toxicity with substructure pattern and random forest
Dong-Sheng Cao et al.
JOURNAL OF CHEMOMETRICS (2012)
Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs
Mei Liu et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2012)
A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data
Hua Yu et al.
PLOS ONE (2012)
Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method
Feixiong Cheng et al.
PLOS ONE (2012)
Data-Driven Prediction of Drug Effects and Interactions
Nicholas P. Tatonetti et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
In silico classification of human maximum recommended daily dose based on modified random forest and substructure fingerprint
Dong-Sheng Cao et al.
ANALYTICA CHIMICA ACTA (2011)
Gaussian interaction profile kernels for predicting drug-target interaction
Twan van Laarhoven et al.
BIOINFORMATICS (2011)
Computational methods for drug repurposing
Philippe Sanseau et al.
BRIEFINGS IN BIOINFORMATICS (2011)
2D MI-DRAGON: A new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins
Francisco Prado-Prado et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors
Giovanni Marzaro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Using entropy of drug and protein graphs to predict FDA drug-target network: Theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica
Francisco Prado-Prado et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Trends in the exploitation of novel drug targets
Mathias Rask-Andersen et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox et al.
NUCLEIC ACIDS RESEARCH (2011)
Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework
Yoshihiro Yamanishi et al.
BIOINFORMATICS (2010)
Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces
Zheng Xia et al.
BMC SYSTEMS BIOLOGY (2010)
An overview of the PubChem BioAssay resource
Yanli Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features
Zhisong He et al.
PLOS ONE (2010)
Supervised prediction of drug-target interactions using bipartite local models
Kevin Bleakley et al.
BIOINFORMATICS (2009)
Protein-ligand interaction prediction: an improved chemogenomics approach
Laurent Jacob et al.
BIOINFORMATICS (2008)
Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
Yoshihiro Yamanishi et al.
BIOINFORMATICS (2008)
Large-scale prediction of drug-target relationships
Michael Kuhn et al.
FEBS LETTERS (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Drug target identification using side-effect similarity
Monica Campillos et al.
SCIENCE (2008)
Drug-target network
Muhammed A. Yildirim et al.
NATURE BIOTECHNOLOGY (2007)
Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data
Nobuyoshi Nagamine et al.
BIOINFORMATICS (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
Structure-based maximal affinity model predicts small-molecule druggability
Alan C. Cheng et al.
NATURE BIOTECHNOLOGY (2007)
Chemogenomic approaches to rational drug design
D. Rognan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Tiqing Liu et al.
NUCLEIC ACIDS RESEARCH (2007)
Protein-ligand docking: Current status and future challenges
Sergio Filipe Sousa et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Chemogenomics: structuring the drug discovery process to gene families
C. John Harris et al.
DRUG DISCOVERY TODAY (2006)
Global mapping of pharmacological space
Gaia V. Paolini et al.
NATURE BIOTECHNOLOGY (2006)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
Chemogenomics: An emerging strategy for rapid target and drug discovery
M Bredel et al.
NATURE REVIEWS GENETICS (2004)
Network biology:: Understanding the cell's functional organization
AL Barabási et al.
NATURE REVIEWS GENETICS (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Lead discovery using molecular docking
BK Shoichet et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2002)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
AAindex: Amino acid index database
S Kawashima et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
